Volume 16 Supplement 3

Sepsis 2012

Open Access

Noradrenergic neurons regulate the egress and trafficking of splenic monocytes and influence mortality during Gram-negative infection in mice

  • EJ Seeley1,
  • S Barry2,
  • M Matthay1 and
  • PJ Wolters1
Critical Care201216(Suppl 3):P71

DOI: 10.1186/cc11758

Published: 14 November 2012

Background

Neurotransmitters derived from the autonomic nervous system can regulate inflammatory cytokine secretion. This has been extensively studied in the parasympathetic nervous system, where acetylcholine regulates the secretion of TNF from splenic macrophages during LPS-induced inflammation. However, the role of noradrenergic neurons during mouse models of infection has not been characterized. The goal of these experiments was to study the influence of noradrenergic neurons on the immune response during Gram-negative septic peritonitis in mice.

Methods

Peripheral noradrenergic nerves were ablated using 6-hydroxydopamine (6-OHDA), a commonly employed method for studying noradrenergic neurons. Four days later, septic peritonitis was induced by i.p. injection of 150 CFU Klebsiella pneumoniae. Survival, serum and peritoneal bacterial loads, inflammatory cytokine production and leukocyte recruitment were studied at multiple time points after infection. To assess the importance of the NE containing splenic nerve, survival experiments on splenectomized mice with or without 6-OHDA treatment were performed.

Results

Ablation of noradrenergic nerves improved survival following K. pneumoniae septic peritonitis (Figure 1A). Mice in which noradrenergic nerves had been ablated showed a more robust immune response 4 hours after infection with higher systemic IL-6, higher intraperitoneal MCP-1 and a fourfold increase in monocyte recruitment into the peritoneum. Bacterial loads were lower 24 and 48 hours after infection in mice in which noradrenergic nerves had been ablated (Figure 1B). Four hours after infection, 6-OHDA-treated mice recruited more inflammatory monocytes to the infected peritoneum (Figure 1D, CTRL vs. 6-OHDA). Splenectomy prior to noradrenergic nerve ablation abrogated the beneficial effects of 6-OHDA during infection (Figure 1C) and reduced the recruitment of monocytes to the infected peritoneum (Figure 1D, 6-OHDA vs. SPLX + 6-OHDA).
https://static-content.springer.com/image/art%3A10.1186%2Fcc11758/MediaObjects/13054_2012_Article_838_Fig1_HTML.jpg
Figure 1

Nonadrenergic nerve ablation with 6-OHDA improves survival during K. pneumonia intraperitoneal sepsis (A). Nonadrenergic nerve ablation leads to improved bacterial killing (B) and enhanced monocyte recruitment 4 hours after infection (D). The survival benefit of 6-OHDA treatment required the spleen because splenectomy (SPLX) prior to 6-OHDA treatment abolishes this survival benefit (C). Peritoneal monocytes were quantified 4 hours after infection in 6-OHDA-treated mice with or without spleens (D). 6-OHDA treatment enhanced the recruitment of splenic monocytes to the peritoneum during infection (D). *P < 0.05.

Conclusion

These results suggest that splenic nerve-derived catecholamines regulate the egress of splenic monocytes during infection and that altering this pathway can alter survival during septic peritonitis in mice. These data highlight the emerging role of splenic monocytes during inflammation and infection [1] and add to the body of evidence that the immunosuppressive effects of catecholamines can impair innate immune responses during infection [2]. These experiments may have important implications for patients receiving vasopressors in the ICU.

Authors’ Affiliations

(1)
University of California
(2)
Stanford University

References

  1. Swirski FK, Nahrendorf M, Etzrodt M, et al.: Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325: 612-616. 10.1126/science.1175202PubMed CentralView ArticlePubMedGoogle Scholar
  2. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P: Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011, 334: 101-105. 10.1126/science.1210301View ArticlePubMedGoogle Scholar

Copyright

© Seeley et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement